Komori
Disclosure3544SATUDORA HOLDINGS CO.,LTD.Retail

Notice Regarding the Borrowing of Funds by Our Subsidiary from Our Parent Company and the Repayment of Borrowings to Financial Institutions with Which We Do Business

The subsidiary will establish a credit facility of up to ¥15 billion from テラ, which is expected to become our parent company, and will borrow approximately ¥13.29 billion. Part of the funds raised will be used to repay approximately ¥13.286 billion in existing borrowings from 15 domestic financial institutions.

Worth reading
69In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
13286461000
Yen (total borrowings under this facility)
Wording
Conditional
How definitive the wording is.

Decision and Details

Board of Directors of Sapporo Drug Store Co., Ltd.

Borrowing of funds by our subsidiary from our parent company and repayment of borrowings to financial institution counterparties

Decision7 August 2026
Period CoveredThe availability period for this facility is from 10 August 2026 through the end of August 2033. The principal repayment date is 7 August 2033.
ImplementationThe borrowings under this facility are scheduled to be drawn on 10 August, 17 August and 24 August 2026. The existing borrowings are scheduled to be repaid from 10 August 2026 onward as appropriate.
Going forwardテラ is scheduled to become our parent company on 10 August 2026. The borrowings under this facility are scheduled to be drawn on 10 August, 17 August and 24 August 2026. The existing borrowings are scheduled to be repaid from 10 August 2026 onward as appropriate.
AmountCredit facility limit: ¥15,000,000,000; total borrowings under this facility: ¥13,286,461,000; total repayment of existing borrowings: ¥13,286 million
Quantity / scaleThe existing borrowings are from 15 domestic financial institutions. The number of shares予定 to be acquired by テラ is 7,290,251 shares.
Reason

This is part of the going-private transaction involving our shares, including the tender offer for our shares by テラ, described in the Notice Regarding the Implementation of an MBO and Recommendation to Tender. One of the conditions for テラ to borrow the funds required for this transaction from Aozora Bank is that SDS repay all of the existing borrowings. The borrowings are also intended to fund working capital and other purposes.

Impact on Business Performance

The impact of the borrowings under this facility and the repayment of the existing borrowings on our results for the fiscal year ending May 2027 is expected to be immaterial.

Decision and Details
ItemDetails
Matter CoveredBorrowing of funds by our subsidiary from our parent company and repayment of borrowings to financial institution counterparties
Decision-Making BodyBoard of Directors of Sapporo Drug Store Co., Ltd.
Decision Date7 August 2026
Implementation DateThe borrowings under this facility are scheduled to be drawn on 10 August, 17 August and 24 August 2026. The existing borrowings are scheduled to be repaid from 10 August 2026 onward as appropriate.
Period CoveredThe availability period for this facility is from 10 August 2026 through the end of August 2033. The principal repayment date is 7 August 2033.
AmountCredit facility limit: ¥15,000,000,000; total borrowings under this facility: ¥13,286,461,000; total repayment of existing borrowings: ¥13,286 million
Quantity / scaleThe existing borrowings are from 15 domestic financial institutions. The number of shares予定 to be acquired by テラ is 7,290,251 shares.
Impact on Business PerformanceThe impact of the borrowings under this facility and the repayment of the existing borrowings on our results for the fiscal year ending May 2027 is expected to be immaterial.
ReasonThis is part of the going-private transaction involving our shares, including the tender offer for our shares by テラ, described in the Notice Regarding the Implementation of an MBO and Recommendation to Tender. One of the conditions for テラ to borrow the funds required for this transaction from Aozora Bank is that SDS repay all of the existing borrowings. The borrowings are also intended to fund working capital and other purposes.
Related previous disclosuresNotice Regarding the Implementation of an MBO and Recommendation to Tender dated 19 June 2026; Corporate Governance Report published on 7 August 2025
Future plansテラ is scheduled to become our parent company on 10 August 2026. The borrowings under this facility are scheduled to be drawn on 10 August, 17 August and 24 August 2026. The existing borrowings are scheduled to be repaid from 10 August 2026 onward as appropriate.
Items this document does not state (1)
Governing Rule

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Full repayment of the existing borrowings is required as a condition for financing the going-private transaction involving our shares through an MBO. The borrowings are also intended to fund working capital and other purposes.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Borrowing of Funds by Our Subsidiary from Our Parent Company and the Repayment of Borrowings to Financial Institutions with Which We Do Business | SATUDORA HOLDINGS CO.,LTD. (3544) timely disclosure | Komori